These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 38901506)
41. Nanotechnology platforms and physiological challenges for cancer therapeutics. Kim KY Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621 [TBL] [Abstract][Full Text] [Related]
42. An update on applications of nanostructured drug delivery systems in cancer therapy: a review. Aberoumandi SM; Mohammadhosseini M; Abasi E; Saghati S; Nikzamir N; Akbarzadeh A; Panahi Y; Davaran S Artif Cells Nanomed Biotechnol; 2017 Sep; 45(6):1-11. PubMed ID: 27632797 [TBL] [Abstract][Full Text] [Related]
43. Facile Construction of i-Motif DNA-Conjugated Gold Nanostars as Near-Infrared and pH Dual-Responsive Targeted Drug Delivery Systems for Combined Cancer Therapy. Miao D; Yu Y; Chen Y; Liu Y; Su G Mol Pharm; 2020 Apr; 17(4):1127-1138. PubMed ID: 32092274 [TBL] [Abstract][Full Text] [Related]
44. DNA nanomaterials for preclinical imaging and drug delivery. Jiang D; England CG; Cai W J Control Release; 2016 Oct; 239():27-38. PubMed ID: 27527555 [TBL] [Abstract][Full Text] [Related]
45. Nanomaterials for cancer therapy: current progress and perspectives. Cheng Z; Li M; Dey R; Chen Y J Hematol Oncol; 2021 May; 14(1):85. PubMed ID: 34059100 [TBL] [Abstract][Full Text] [Related]
46. New insights into polysaccharide-based nanostructured delivery systems in breast cancer: Possible application of antisense oligonucleotides in breast cancer therapy. Shayegh F; Türk Z; Armani A; Zarghami N Int J Biol Macromol; 2024 Jun; 272(Pt 2):132890. PubMed ID: 38848829 [TBL] [Abstract][Full Text] [Related]
47. Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure. Khan AU; Khan M; Cho MH; Khan MM Bioprocess Biosyst Eng; 2020 Aug; 43(8):1339-1357. PubMed ID: 32193755 [TBL] [Abstract][Full Text] [Related]
48. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring. Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832 [TBL] [Abstract][Full Text] [Related]
49. "Combo" nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy. Kemp JA; Shim MS; Heo CY; Kwon YJ Adv Drug Deliv Rev; 2016 Mar; 98():3-18. PubMed ID: 26546465 [TBL] [Abstract][Full Text] [Related]
50. Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review. Fathi-Karkan S; Arshad R; Rahdar A; Ramezani A; Behzadmehr R; Ghotekar S; Pandey S Eur J Med Chem; 2023 Nov; 259():115676. PubMed ID: 37499287 [TBL] [Abstract][Full Text] [Related]
51. Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer. van Eerden RAG; Mathijssen RHJ; Koolen SLW Int J Nanomedicine; 2020; 15():8151-8166. PubMed ID: 33132699 [TBL] [Abstract][Full Text] [Related]
52. (Nano)biotechnological approaches in the treatment of cervical cancer: integration of engineering and biology. Xie W; Xu Z Front Immunol; 2024; 15():1461894. PubMed ID: 39346915 [TBL] [Abstract][Full Text] [Related]
53. [Research progress in co-delivery of gene and chemotherapy drugs with nanocarriers for cancer therapy]. Chen WG; Wang SB Yao Xue Xue Bao; 2013 Jul; 48(7):1091-8. PubMed ID: 24133974 [TBL] [Abstract][Full Text] [Related]
54. DNA Origami: From Molecular Folding Art to Drug Delivery Technology. Jiang Q; Shang Y; Xie Y; Ding B Adv Mater; 2024 May; 36(22):e2301035. PubMed ID: 37715333 [TBL] [Abstract][Full Text] [Related]
55. The Growing Development of DNA Nanostructures for Potential Healthcare-Related Applications. Mathur D; Medintz IL Adv Healthc Mater; 2019 May; 8(9):e1801546. PubMed ID: 30843670 [TBL] [Abstract][Full Text] [Related]
56. DNA origami as an in vivo drug delivery vehicle for cancer therapy. Zhang Q; Jiang Q; Li N; Dai L; Liu Q; Song L; Wang J; Li Y; Tian J; Ding B; Du Y ACS Nano; 2014 Jul; 8(7):6633-43. PubMed ID: 24963790 [TBL] [Abstract][Full Text] [Related]
57. Nano-Phytosome: A Developing Platform for Herbal Anti-Cancer Agents in Cancer Therapy. Babazadeh A; Zeinali M; Hamishehkar H Curr Drug Targets; 2018; 19(2):170-180. PubMed ID: 28482783 [TBL] [Abstract][Full Text] [Related]
58. pH-sensitive nano-systems for drug delivery in cancer therapy. Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541 [TBL] [Abstract][Full Text] [Related]
59. A Nanobody-Conjugated DNA Nanoplatform for Targeted Platinum-Drug Delivery. Wu T; Liu J; Liu M; Liu S; Zhao S; Tian R; Wei D; Liu Y; Zhao Y; Xiao H; Ding B Angew Chem Int Ed Engl; 2019 Oct; 58(40):14224-14228. PubMed ID: 31389144 [TBL] [Abstract][Full Text] [Related]
60. Engineered Polymer-Based Nanomaterials for Diagnostic, Therapeutic and Theranostic Applications. Parisi OI; Scrivano L; Sinicropi MS; Picci N; Puoci F Mini Rev Med Chem; 2016; 16(9):754-61. PubMed ID: 26156541 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]